MyMilo v1.x.x

Nom de l'organisation
Code d'UDI-DI
Numéro de référence/catalogue

Rôle
Pays
Date d'enregistrement
Adresse

Avertissements critiques

15 avertissements enregistrés — faire défiler le panneau pour tout voir.

CW999
The app should not be used if exercise or physical activity has been prohibited by a doctor. Before using the app, the listed warnings and contraindications should be clarified with a healthcare professional.
CW999
The app is only intended for use by children in a stable general medical condition. The environment must be safe, non-slip, and well-lit. If the child is provided with aids (e.g., orthotics), these must be correctly fitted and approved by a doctor.
CW999
The app should not be used if you are feeling generally unwell, have a fever, upper respiratory tract infections (e.g., cold or flu), acute inflammation, dizziness, or light-headedness. If you experience any of these symptoms, you should stop training and seek medical advice if necessary.
CW999
Training must also be stopped immediately if there are local problems in the area of the body being trained (e.g., redness, swelling, wound healing disorders, infections, hematomas, or signs of thrombosis). Training should only be resumed after consulting a doctor.
CW999
In the event of the following laboratory chemical and blood count changes: - Thrombocytes ≤ 20,000/μl (thrombocyte count measured daily during hospitalization, at least twice a week after discharge) upon admission to hospital - Adolescents with Quick ≤ 50% - Adolescents with prolonged PTT >40 sec. - Adolescents with clinically relevant haemorrhagic diathesis. These include: Thrombocytopathies - Bernard-Soulier syndrome - Glanzmann-Naegeli thrombasthenia Thrombocytopenia - Myelodysplastic syndrome (MDS) (if relevant cytopenias and clinical bleeding tendency are present) - Idiopathic thrombocytopenic purpura (ITP) - Thrombotic thrombocytopenic purpura (TTP) - Post-transfusion purpura (PTP, rare) - Heparin-induced thrombocytopenia (HIT II, no restrictions in mild HIT I) Coagulopathies - Haemophilia A - Haemophilia B - Von Willebrand disease (in severe cases) - Consumptive coagulopathy - Primary hyperfibrinolysis Vascular haemorrhagic diatheses - Osler's disease - Schoenlein-Henoch purpura - Vasculitis
CW999
Children with pre-existing cardiac, pulmonary, neurological, or vascular conditions, autoimmune diseases, metabolic disorders (e.g., diabetes), increased risk of bleeding—especially if platelet counts are below 20,000/μl — or existing pregnancy should only use the app after it has been expressly approved by their treating physician. The same applies to regular use of medications such as steroids or anticoagulants.
CW999
Impairments of the musculoskeletal system that increase the risk of fracture due to instability of the musculoskeletal system, e.g., osteonecrosis, bone metastases at risk of fracture
CW999
In the event of a medical restriction on movement (e.g., post-operative). Approval for “stress and training stability” must be obtained before use.
CW999
Relevant cytopenias in the context of the underlying disease or as a result of therapy, especially in cases of: - Absolute neutrophil count < 0.5 G/L - Thrombocytes < 50 G/L - Hb < 70 g/L
CW999
Children undergoing therapeutic anticoagulation (e.g., direct anticoagulants, vitamin K antagonists, off-label dual platelet inhibition).
CW999
Children undergoing antiplatelet therapy with acetylsalicylic acid (monotherapy)
CW999
Children and adolescents with central nervous system disorders or mental and behavioral disorders (ICD-10 Chapter F) who, according to medical assessment, are at clinically relevant risk of unexpected reactions or self-harm or harm to others during app use due to limited behavioral or impulse control.
CW999
Children with relevant cardiac diseases and valve defects that already prohibit mild exercise.
CW999
Children and adolescents with epilepsy or other neurological disorders with known hypersensitivity, especially with known triggers from visual or auditory stimuli, who, according to medical assessment, are at increased risk of seizure-related or unexpected reactions during app use.
CW999
Children and adolescents with neurological diseases or functional disorders who, in the opinion of a physician, are at clinically relevant risk during app use due to gait or balance disorders, increased risk of falling, or relevant sensory deficits (e.g., hypoesthesia, paraesthesia).

Informations sur le fabricant

Certificats

Dispositifs connexes

Informations sur le fabricant

Avertissements critiques

Distribution sur le marché

Identification du dispositif

Classification

Détails sur le dispositif

Code(s) de la nomenclature (EMDN)

Indicateurs de conformité

Sécurité

Substances

Réglementaire

Cycle de vie

Traçabilité UDI-PI

Dispositifs connexes

Certificats